Effect of academic detailing on the utilization of intravenous antimicrobial therapy

Gibbons, 1992, Exploring new strategies to fight drug-resistant microbes, Science, 257, 1036, 10.1126/science.257.5073.1036 Cohen, 1992, Epidemiology of drug resistance: Implications for a post-antimicrobial era, Science, 257, 1050, 10.1126/science.257.5073.1050 Avorn, 1988, Reduction in incorrect antibiotic dosing through a structured educational order form, Arch Intern Med, 140, 1720, 10.1001/archinte.1988.00380080024009 McGowan, 1983, Antimicrobial resistance in hospital organisms and its relation to antibiotic use, Rev Infect Dis, 5, 1033, 10.1093/clinids/5.6.1033 Soumerai, 1990, Principles of educational outreach (“academic detailing”) to improve clinical decision making, JAMA, 263, 549, 10.1001/jama.1990.03440040088034 Soumerai, 1986, Economic and policy analysis of university-based drug “detailing”, Med Care, 24, 313, 10.1097/00005650-198604000-00003 Soumerai, 1984, Efficacy and cost-containment in hospital pharmacotherapy: State of the art and future directions, Milbank Mem Fund Q, 62, 447, 10.2307/3349860 Avorn, 1983, Improving drug-therapy decisions through educational outreach: A randomized controlled trial of academically based “detailing”, New Engl J Med, 308, 1457, 10.1056/NEJM198306163082406 Buckley, 1992, Imipenem/cilastatin: A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy, Drugs, 44, 408, 10.2165/00003495-199244030-00008 Baum, 1986, Drug utilization in the United States Avorn, 1982, Scientific versus commercial sources of influence on the prescribing behavior of physicians, Am J Med, 73, 4, 10.1016/0002-9343(82)90911-1 Wilkes, 1992, Pharmaceutical advertisements in leading medical journals: Experts' assessments, Ann Intern Med, 116, 912, 10.7326/0003-4819-116-11-912